Spatial distribution of MRI-determined hepatic proton density fat fraction in adults with nonalcoholic fatty liver disease

Journal of Magnetic Resonance Imaging

Volumn 39, Issue 6, 2014, Pages 1525-1532

  Bonekamp, Susanne ^a   Tang, An ^b,c   Mashhood, Arian ^b   Wolfson, Tanya ^d   Changchien, Christopher ^b   Middleton, Michael S ^b   Clark, Lisa ^b   Gamst, Anthony ^d   Loomba, Rohit ^e   Sirlin, Claude B ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MONTREAL   (Canada)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

liver fat; MR imaging based fat quantification; nonalcoholic fatty liver disease; proton density fat fraction; variability of hepatic steatosis

Indexed keywords

PROTON;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; HUMAN; IMAGE ANALYSIS; LINEAR REGRESSION ANALYSIS; MALE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROTON DENSITY FAT FRACTION; RADIOLOGICAL PARAMETERS; SPATIAL ANALYSIS; STATISTICAL ANALYSIS; YOUNG ADULT; COMPUTER ASSISTED DIAGNOSIS; CROSS-SECTIONAL STUDY; IMAGE PROCESSING; LIVER; OBESITY; PATHOLOGY; PROCEDURES; PROSPECTIVE STUDY;

ADIPOSITY; ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGE PROCESSING, COMPUTER-ASSISTED; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PROSPECTIVE STUDIES; PROTONS; YOUNG ADULT;

EID: 84900011091     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.24321     Document Type: Article

References (45)

1. Lazo M, Clark JM, the epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis 2008; 28: 339-350.
2. Szczepaniak LS, Nurenberg P, Leonard D, et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 2005; 288: E462-E468.
3. Williams CD, Stengel J, Asike MI, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011; 140: 124-131.
4. Loomba R, Abraham M, Unalp A, et al. Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis. Hepatology 2012; 56: 943-951.
5. Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001; 50: 1844-1850.
6. Bugianesi E, Moscatiello S, Ciaravella MF, Marchesini G,. Insulin resistance in nonalcoholic fatty liver disease. Curr Pharm Des 2010; 16: 1941-1951.
7. Neuschwander-Tetri BA, Clark JM, Bass NM, et al. Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. Hepatology 2010; 52: 913-924.
8. Korenblat KM, Fabbrini E, Mohammed BS, Klein S,. Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. Gastroenterology 2008; 134: 1369-1375.
9. Francque S, Verrijken A, Mertens I, et al. Visceral adiposity and insulin resistance are independent predictors of the presence of non-cirrhotic NAFLD-related portal hypertension. Int J Obes (Lond) 2011; 35: 270-278.
10. Larter CZ, Chitturi S, Heydet D, Farrell GC,. A fresh look at NASH pathogenesis. Part 1: the metabolic movers. J Gastroenterol Hepatol 2010; 25: 672-690.
11. Farrell GC, Larter CZ,. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006; 43: S99-S112.
12. Fabbrini E, Mohammed BS, Magkos F, Korenblat KM, Patterson BW, Klein S,. Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. Gastroenterology 2008; 134: 424-431.
13. Ulitsky A, Ananthakrishnan AN, Komorowski R, et al. A noninvasive clinical scoring model predicts risk of nonalcoholic steatohepatitis in morbidly obese patients. Obes Surg 2010; 20: 685-691.
14. Lee JY, Kim KM, Lee SG, et al. Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center. J Hepatol 2007; 47: 239-244.
15. el-Hassan AY, Ibrahim EM, al-Mulhim FA, Nabhan AA, Chammas MY,. Fatty infiltration of the liver: analysis of prevalence, radiological and clinical features and influence on patient management. Br J Radiol 1992; 65: 774-778.
16. Grove A, Vyberg B, Vyberg M., Focal fatty change of the liver. A review and a case associated with continuous ambulatory peritoneal dialysis. Virchows Arch A Pathol Anat Histopathol 1991; 419: 69-75.
17. Merriman RB, Ferrell LD, Patti MG, et al. Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease. Hepatology 2006; 44: 874-880.
18. Larson SP, Bowers SP, Palekar NA, Ward JA, Pulcini JP, Harrison SA,. Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypass. Clin Gastroenterol Hepatol 2007; 5: 1329-1332.
19. Ratziu V, Charlotte F, Heurtier A, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005; 128: 1898-1906.
20. Johnson NA, Walton DW, Sachinwalla T, et al. Noninvasive assessment of hepatic lipid composition: advancing understanding and management of fatty liver disorders. Hepatology 2008; 47: 1513-1523.
21. van Werven JR, Hoogduin JM, Nederveen AJ, et al. Reproducibility of 3.0 Tesla magnetic resonance spectroscopy for measuring hepatic fat content. J Magn Reson Imaging 2009; 30: 444-448.
22. Kang BK, Yu ES, Lee SS, et al. Hepatic fat quantification: a prospective comparison of magnetic resonance spectroscopy and analysis methods for chemical-shift gradient echo magnetic resonance imaging with histologic assessment as the reference standard. Invest Radiol 2012; 47: 368-375.
23. Hines CD, Frydrychowicz A, Hamilton G, et al. T(1) independent, T(2) corrected chemical shift based fat-water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis. J Magn Reson Imaging 2011; 33: 873-881.
24. Yokoo T, Bydder M, Hamilton G, et al. Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology 2009; 251: 67-76.
25. Yokoo T, Shiehmorteza M, Hamilton G, et al. Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. Radiology 2011; 258: 749-759.
26. Kang GH, Cruite I, Shiehmorteza M, et al. Reproducibility of MRI-determined proton density fat fraction across two different MR scanner platforms. J Magn Reson Imaging 2011; 34: 928-934.
27. Hussain HK, Chenevert TL, Londy FJ, et al. Hepatic fat fraction: MR imaging for quantitative measurement and display-early experience. Radiology 2005; 237: 1048-1055.
28. Bydder M, Yokoo T, Hamilton G, et al. Relaxation effects in the quantification of fat using gradient echo imaging. Magn Reson Imaging 2008; 26: 347-359.
29. Liu CY, McKenzie CA, Yu H, Brittain JH, Reeder SB,. Fat quantification with IDEAL gradient echo imaging: correction of bias from T(1) and noise. Magn Reson Med 2007; 58: 354-364.
30. Yu H, McKenzie CA, Shimakawa A, et al. Multiecho reconstruction for simultaneous water-fat decomposition and T2* estimation. J Magn Reson Imaging 2007; 26: 1153-1161.
31. Couinaud C,. Surgical anatomy of the liver revisited, 1st edition. Paris, France: Maugein and Cie Press; 1989.
32. Hamilton G, Yokoo T, Bydder M, et al. In vivo characterization of the liver fat (1) H MR spectrum. NMR Biomed 2011; 24: 784-790.
33. Jones R, Payne B, editors,. Clinical investigation and statistics in laboratory medicine. London: ACB Venture Publications; 1997.
34. Good PI,. Permutation tests: a practical guide to resampling methods for testing hypotheses, 2nd edition. New York: Springer; 2000. 270 p.
35. Romano JP,. Bootstrap and randomization tests of some nonparametric hypotheses. Ann Stat 1989; 17: 141-159.
36. Hochberg Y,. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 1988; 75: 800-802.
37. Meisamy S, Hines CD, Hamilton G, et al. Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy. Radiology 2011; 258: 767-775.
38. Permutt Z, Le TA, Peterson, MR, et al. Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease-MRI accurately quantifies hepatic steatosis in NAFLD. Aliment Pharmacol Ther 2012; 36: 22-29.
39. Sirlin CB, Reeder SB,. Magnetic resonance imaging quantification of liver iron. Magn Reson Imaging Clin N Am 2010; 18: 359-381, ix.
40. Reeder SB, Cruite I, Hamilton G, Sirlin CB,. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging 2011; 34: 729-749.
41. Qayyum A, Goh JS, Kakar S, Yeh BM, Merriman RB, Coakley FV,. Accuracy of liver fat quantification at MR imaging: comparison of out-of-phase gradient-echo and fat-saturated fast spin-echo techniques-initial experience. Radiology 2005; 237: 507-511.
42. Tsang SW, Ng WF, Wu BP, Chow DA, Li ET, Wong TC,. Predictors of fibrosis in Asian patients with non-alcoholic steatohepatitis. J Gastroenterol Hepatol 2006; 21: 116-121.
43. Nomura F, Ohnishi K, Ochiai T, Okuda K,. Obesity-related nonalcoholic fatty liver: CT features and follow-up studies after low-calorie diet. Radiology 1987; 162: 845-847.
44. Copher GH, Dick B,. " Stream line" phenomena in the portal vein and the selective distribution of portal blood in the liver. Arch Surg 1928; 17: 408-419.
45. Hahn PF, Donald WD, Grier RCJ, the physiological bilaterality of the portal circulation Am J Physiol 1945; 143: 105-107.